NDC 73377-094-01 - Losartan Potassium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73377-094
- Requested NDC
- 73377-094-01
- Package NDCs from labels
- 73377-094-01, 73377-094-02, 73377-094-03, 73377-094-04, 73377-094-05, 73377-094-06, 73377-094-07
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2026-05-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Losartan Potassium - AX Pharmaceutical Corp | AX Pharmaceutical Corp | 2026-05-19 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73377-094-01 | Losartan Potassium | 100 g in 1 JAR | POWDER | 100 | 7 | |
| 73377-094-02 | Losartan Potassium | 25 g in 1 JAR | POWDER | 25 | 7 | |
| 73377-094-03 | Losartan Potassium | 1000 g in 1 JAR | POWDER | 1000 | 7 | |
| 73377-094-04 | Losartan Potassium | 97 g in 1 JAR | POWDER | 97 | 7 | |
| 73377-094-05 | Losartan Potassium | 80 g in 1 JAR | POWDER | 80 | 7 | |
| 73377-094-06 | Losartan Potassium | 500 g in 1 JAR | POWDER | 500 | 7 | |
| 73377-094-07 | Losartan Potassium | 1500 g in 1 JAR | POWDER | 1500 | 7 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | DIRECT RX | a58c56b2-e05c-6697-e053-2a95a90ad466 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Direct_Rx | 8de04bf2-83dd-c494-e053-2a95a90abade | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | de5c0c87-e90b-fc14-e053-2a95a90af0c5 | 2024-12-26 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Quality Care Products, LLC | a6241e63-1952-4dfa-ba94-c406059501dd | 2024-12-19 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan potassium Tablets, 25 mg | LOSARTAN POTASSIUM | Jubilant Cadista Pharmaceuticals Inc. | 1bf520a2-a50e-a6ae-0fdf-9be4e69729c0 | 2024-12-12 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 927315ca-211b-4976-b228-cf544f7e5259 | 2024-11-26 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | Bryant Ranch Prepack | 43fa4762-cc0c-4a3b-a527-6aa7fb7c5464 | 2024-08-27 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | A-S Medication Solutions | f68fd1a2-1cbf-47c8-b8c4-df49cf17540e | 2024-08-26 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | Bryant Ranch Prepack | de987691-f659-45ab-9c53-402ef7421f4b | 2024-08-26 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 98b97680-474c-4e70-89dd-15bb49773125 | 2024-08-21 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | Proficient Rx LP | 4b298291-4251-4af8-a436-58a3443a7978 | 2024-08-01 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| LOSARTAN POTASSIUM 100 mg | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | a955160f-3c2d-3366-e053-2a95a90a65ea | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | aa58c629-f7d9-a6e0-e053-2995a90ac188 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,iNc. | 54b363c4-00bb-08db-e054-00144ff8d46c | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | af44b2b0-1204-43c9-8ec1-d081d35b8f2b | 2024-06-28 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 9c0809dc-cbdd-1a33-e053-2995a90a4825 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 9f1c20aa-2028-412d-e053-2995a90a1368 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | a11075f1-f7d0-0c3d-e053-2995a90a0c9d | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | a1123700-f4c7-2b62-e053-2a95a90a87d6 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | 9130921b-02f0-82d6-e053-2995a90a9c0a | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.